It got FDA approval Friday evening and it;s the only FDA approved drug for the treatment of pseudobulbar affect (PBA)...Huge market for this drug and great chance for the buyout...Analyst have predicted stock price of $9 - $12 after FDA approval...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.